Circassia Pharmaceuticals: Strong Financial Performance and Strategic Transitions Drive Buy Rating
Analyst James Orsborne of Stifel Nicolaus assigned a Buy rating on Circassia Pharmaceuticals (NIOX – Research Report), with a price target of ...
Niox Group upgraded to Buy from Hold at Panmure Liberum
Panmure Liberum upgraded Niox Group (CSSPF) to Buy from Hold with a 69 GBp price target Stay Ahead of the Market:Discover outperforming stocks ...
newarab20d
Ukraine parliament recognises Circassian genocide in win for MENA activists
Circassian activists, like many displaced populations, have been challenged by different time zones and borders, but online cooperation has helped them overcome these logistical hurdles, spearheaded ...